| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Peter Weber | |
| Barbara Troesch | |||
| M. Hasan Mohajeri | |||
| P2860 | cites work | Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial | Q21136174 |
| Alzheimer Disease in the US Population | Q22253055 | ||
| Appraising the brain's energy budget | Q22337193 | ||
| Omega-3 fatty acids: potential role in the management of early Alzheimer's disease | Q24595490 | ||
| Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial | Q24607545 | ||
| Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthood | Q24628945 | ||
| A critical review of vitamin C for the prevention of age-related cognitive decline and Alzheimer's disease | Q24634751 | ||
| Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals | Q26995405 | ||
| Neuropathological alterations in Alzheimer disease | Q27003314 | ||
| Vitamin E: function and metabolism | Q28138332 | ||
| Serum levels of beta-carotene, alpha-carotene and vitamin A in patients with Alzheimer's disease | Q28199260 | ||
| Treatment of vitamin b(12)-deficiency anemia: oral versus parenteral therapy | Q28207535 | ||
| Intake of selected nutrients from foods, from fortification and from supplements in various European countries. | Q37469894 | ||
| Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline | Q37678546 | ||
| Residency and specialties training in nutrition: a call for action | Q37700620 | ||
| Neurodevelopment and neurodegeneration: are there critical stages for nutritional intervention? | Q37800154 | ||
| Amyloid-independent mechanisms in Alzheimer's disease pathogenesis | Q37808579 | ||
| A family with spinocerebellar ataxia type 8 expansion and vitamin E deficiency ataxia | Q28216795 | ||
| Subacute sensory ataxia and optic neuropathy with thiamine deficiency | Q28277383 | ||
| Chemistry and biology of vitamin E | Q28296736 | ||
| Enough is enough: Stop wasting money on vitamin and mineral supplements | Q28307171 | ||
| Multivitamin use and telomere length in women | Q28389864 | ||
| Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial | Q30584897 | ||
| Vitamin B12 (cobalamin) deficiency in elderly patients | Q30769878 | ||
| Alzheimer's disease: clinical trials and drug development | Q33349401 | ||
| Vitamin D and cognitive performance in adults: a systematic review. | Q33491244 | ||
| 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services | Q33601267 | ||
| Approaches toward new Alzheimer's treatments | Q33630417 | ||
| Vitamin D and neurocognitive dysfunction: preventing "D"ecline? | Q33693884 | ||
| Current concepts in cobalamin deficiency | Q33896073 | ||
| Vitamin E and its function in membranes | Q33900377 | ||
| Vitamin E: non-antioxidant roles | Q33900909 | ||
| Tau aggregation into fibrillar polymers: taupathies | Q33957159 | ||
| Effects of folic acid supplementation on hearing in older adults: a randomized, controlled trial | Q34001733 | ||
| Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L- carnitine and/or R-alpha -lipoic acid | Q34011426 | ||
| Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases | Q34027672 | ||
| Dietary intakes of vitamin E, vitamin C, and β-carotene and risk of Alzheimer's disease: a meta-analysis | Q34031686 | ||
| Osteoporosis and the role of vitamin D and calcium-vitamin D deficiency, vitamin D insufficiency and vitamin D sufficiency | Q34031687 | ||
| Dietary intake and cognitive function in a group of elderly people. | Q34065268 | ||
| Genetic, epigenetic and posttranslational mechanisms of aging | Q34098894 | ||
| Neuronutrition and Alzheimer's disease | Q34099466 | ||
| Vitamin E and neurological function | Q34100572 | ||
| Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline | Q34113201 | ||
| Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift | Q34160589 | ||
| Alpha-tocopherol induces expression of connective tissue growth factor and antagonizes tumor necrosis factor-alpha-mediated downregulation in human smooth muscle cells | Q34169724 | ||
| Vitamin C as an antioxidant: evaluation of its role in disease prevention | Q34175262 | ||
| Failure to modulate attentional control in advanced aging linked to white matter pathology | Q34201217 | ||
| Dopamine-beta-hydroxylase | Q34210661 | ||
| Ascorbic Acid and Reaction Kinetics in situ: A New Approach to Vitamin Requirements | Q34230744 | ||
| The effects of multivitamins on cognitive performance: a systematic review and meta-analysis. | Q34254086 | ||
| Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia | Q35600979 | ||
| Age and diagnostic performance of Alzheimer disease CSF biomarkers. | Q35758640 | ||
| A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly | Q35834686 | ||
| Reduced risk of Alzheimer's disease with high folate intake: the Baltimore Longitudinal Study of Aging | Q36034184 | ||
| Nutritional factors in physical and cognitive functions of elderly people | Q36132126 | ||
| What is an adequate dose of oral vitamin B12 in older people with poor vitamin B12 status? | Q36587820 | ||
| Multivitamin-multimineral supplements: who uses them? | Q36701918 | ||
| Ageing and the gut | Q36724430 | ||
| Indices of metabolic dysfunction and oxidative stress | Q36753383 | ||
| Biological aging is no longer an unsolved problem | Q36802089 | ||
| Dietary folate, vitamin B-12, vitamin B-6 and incident Alzheimer's disease: the cache county memory, health and aging study | Q36822633 | ||
| The role of vitamins and minerals in energy metabolism and well-being | Q36861425 | ||
| Antibody-based approaches in Alzheimer's research: safety, pharmacokinetics, metabolism, and analytical tools | Q36994607 | ||
| Prognostic impact of disease-related malnutrition | Q37025235 | ||
| Nucleic acid oxidation in Alzheimer disease | Q37079369 | ||
| A life course of adiposity and dementia | Q37142566 | ||
| Dementia prevention: methodological explanations for inconsistent results | Q37263684 | ||
| Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study | Q34274231 | ||
| Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults | Q34311853 | ||
| Gene regulation and DNA damage in the ageing human brain | Q34326236 | ||
| Oxidative damage and mitochondrial decay in aging | Q34326443 | ||
| Vitamins - wrong approaches | Q34353300 | ||
| Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease | Q34386896 | ||
| Long-term multivitamin supplementation and cognitive function in men: a randomized trial | Q34401809 | ||
| B vitamins, cognition, and aging: a review | Q34420899 | ||
| Vitamin D3 enhances mood in healthy subjects during winter | Q34463747 | ||
| The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease | Q34526501 | ||
| Relation of higher folate intake to lower risk of Alzheimer disease in the elderly | Q34573863 | ||
| Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage | Q34581373 | ||
| Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease | Q34598371 | ||
| High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial | Q34598450 | ||
| Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. | Q34605131 | ||
| Does senescence give rise to disease? | Q34609989 | ||
| The influence of micronutrients on cognitive function and performance | Q34615634 | ||
| The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications | Q34626915 | ||
| Relations between homocysteine, folate and vitamin B12 in vascular dementia and in Alzheimer disease | Q34632104 | ||
| Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment | Q34652047 | ||
| Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses. | Q34711683 | ||
| A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. | Q34712920 | ||
| The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease | Q34750643 | ||
| Elevated levels of tau in cerebrospinal fluid: implications for the antemortem diagnosis of Alzheimer's disease elevated levels of tau in cerebrospinal fluid: implications for the antemortem diagnosis of Alzheimer's disease. | Q34817713 | ||
| Rapid resolution of delusional parasitosis in pellagra with niacin augmentation therapy | Q34897438 | ||
| Eating well: ageing gracefully! | Q35030776 | ||
| Gut changes attributed to ageing: effects on intestinal microflora | Q35032413 | ||
| Food intake in the real world: implications for nutrition and aging | Q35074154 | ||
| Vitamin nutrition in older adults | Q35074169 | ||
| Monitoring of vitamin B-12 nutritional status in the United States by using plasma methylmalonic acid and serum vitamin B-12. | Q35125377 | ||
| Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither? | Q35175404 | ||
| Foods, fortificants, and supplements: Where do Americans get their nutrients? | Q35217828 | ||
| Advanced glycation end product level, diabetes, and accelerated cognitive aging | Q35240099 | ||
| The role of alpha-tocopherol in preventing disease: from epidemiology to molecular events | Q35571305 | ||
| Vitamin D, neurocognitive functioning and immunocompetence | Q37811848 | ||
| Antioxidants in health, disease and aging | Q37827886 | ||
| Alzheimer's disease: synapses gone cold | Q37922808 | ||
| Oxidation as "the stress of life". | Q37938589 | ||
| Dietary surveys indicate vitamin intakes below recommendations are common in representative Western countries | Q38018138 | ||
| Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis | Q38050051 | ||
| Weight loss and Alzheimer's disease: temporal and aetiologic connections | Q38056572 | ||
| Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms. | Q38396432 | ||
| Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial | Q38487526 | ||
| Resolving controversies on the path to Alzheimer's therapeutics | Q39709721 | ||
| Aging and excitotoxic stress exacerbate neural circuit reorganization in amyloid precursor protein intracellular domain transgenic mice | Q41908070 | ||
| Alzheimer's disease: development of disease-modifying treatments is the challenge for our generation | Q42342190 | ||
| Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer's disease. | Q42352469 | ||
| High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age. | Q43088178 | ||
| Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients | Q43666328 | ||
| Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene: a study in an Italian population with dementia. | Q43758860 | ||
| Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study. | Q43807755 | ||
| The North/South Ireland Food Consumption Survey: vitamin intakes in 18-64-year-old adults | Q43872301 | ||
| Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease | Q43999932 | ||
| Homocysteine, vitamin B6, and vascular disease in AD patients | Q44009306 | ||
| Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study | Q44036291 | ||
| 2011 Alzheimer's disease facts and figures | Q44040789 | ||
| Vitamin E and cognitive decline in older persons | Q44063663 | ||
| Consumption of energy-dense, nutrient-poor foods by adult Americans: nutritional and health implications. The third National Health and Nutrition Examination Survey, 1988-1994. | Q44115370 | ||
| Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland | Q44168381 | ||
| Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment | Q44464005 | ||
| Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. | Q44555815 | ||
| Cobalamin, folate, methylmalonic acid, homocysteine, and gastritis markers in dementia | Q44598460 | ||
| Association of plasma homocysteine in elderly persons with atherosclerotic vascular disease and dementia, atherosclerotic vascular disease without dementia, dementia without atherosclerotic vascular disease, and no dementia or atherosclerotic vascul | Q44699006 | ||
| Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel | Q44855083 | ||
| Homocysteine in Alzheimer disease and vascular dementia | Q44944673 | ||
| The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study | Q44957795 | ||
| Plasma homocysteine concentration relates to the severity but not to the duration of Alzheimer's disease | Q44979250 | ||
| Homocysteine, vitamin B12 and folate in vascular dementia and in Alzheimer disease. | Q45117714 | ||
| Is antioxidant use protective of cognitive function in the community-dwelling elderly? | Q45157244 | ||
| Nutritional status of free-living Alzheimer's patients | Q45188636 | ||
| Plasma homocysteine levels and cognitive status in long-term stay geriatric patients: a cross-sectional study | Q45244222 | ||
| Effect of an antioxidant drink on homocysteine levels in Alzheimer's patients. | Q45593716 | ||
| Telomere shortening in elderly individuals with mild cognitive impairment may be attenuated with ω-3 fatty acid supplementation: a randomized controlled pilot study | Q45766226 | ||
| High fruit and vegetable intake is positively correlated with antioxidant status and cognitive performance in healthy subjects. | Q45960521 | ||
| Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. | Q46568948 | ||
| Medial temporal lobe atrophy, apolipoprotein genotype, and plasma homocysteine in Sri Lankan patients with Alzheimer's disease. | Q46612729 | ||
| Homocysteine and B vitamins in mild cognitive impairment and dementia | Q46729826 | ||
| A cross-sectional study of homocysteine-, NO-levels, and CT-findings in Alzheimer dementia, vascular dementia and controls. | Q46839979 | ||
| An Aging World--demographics and challenges | Q47568912 | ||
| An Index of Food Quality | Q47961200 | ||
| Anti-apoptotic wild-type Alzheimer amyloid precursor protein signaling involves the p38 mitogen-activated protein kinase/MEF2 pathway | Q48427045 | ||
| Amyloid-beta: a (life) preserver for the brain | Q48430388 | ||
| Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction | Q48448398 | ||
| Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial | Q48589289 | ||
| Elevated oxidative stress and decreased antioxidant function in the human hippocampus and frontal cortex with increasing age: implications for neurodegeneration in Alzheimer's disease | Q48591601 | ||
| Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. | Q48630088 | ||
| Higher vitamin D dietary intake is associated with lower risk of alzheimer's disease: a 7-year follow-up | Q48697430 | ||
| A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study | Q48725577 | ||
| Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study | Q48918091 | ||
| Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: a 7-year longitudinal study. | Q50772000 | ||
| Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. | Q50856492 | ||
| Fundic atrophic gastritis in an elderly population. Effect on hemoglobin and several serum nutritional indicators. | Q51632149 | ||
| Plasma homocysteine, cobalamin/folate status, and vascular disease in a large population of psychogeriatric patients. | Q51912962 | ||
| Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. | Q51949735 | ||
| Hyperhomocysteinemia in dementia. | Q51965160 | ||
| Reduced gastrointestinal absorption of calcium in dementia. | Q53185585 | ||
| Calcium metabolism in Alzheimer's disease. A case-control study. | Q53189240 | ||
| High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease. | Q53225654 | ||
| Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease. | Q53250272 | ||
| Alzheimer's disease in Brazilian elderly has a relation with homocysteine but not with MTHFR polymorphisms. | Q53284188 | ||
| The underestimated potential of the immune system in prevention of Alzheimer's disease pathology. | Q53288438 | ||
| Alzheimer's researchers call for clinical revamp. | Q53317295 | ||
| Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohort | Q56992986 | ||
| Vitamin E may affect the life expectancy of men, depending on dietary vitamin C intake and smoking | Q57256322 | ||
| Amyloid-β junkies | Q57342137 | ||
| Tocopherols and tocotrienols plasma levels are associated with cognitive impairment | Q57971975 | ||
| A cost constraint alone has adverse effects on food selection and nutrient density: an analysis of human diets by linear programming | Q62629466 | ||
| Bone density, vitamin D nutrition, and parathyroid hormone levels in women with dementia | Q71745953 | ||
| Age-related changes in spontaneous food intake and hunger in humans | Q72324722 | ||
| Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? | Q73133082 | ||
| Abnormal amino acid metabolism in patients with early stage Alzheimer dementia | Q74770300 | ||
| Plasma vitamin B-6 forms and their relation to transsulfuration metabolites in a large, population-based study | Q80580108 | ||
| Older adults who use vitamin/mineral supplements differ from nonusers in nutrient intake adequacy and dietary attitudes | Q80692271 | ||
| Increased autophagic degradation of mitochondria in Alzheimer disease | Q81040118 | ||
| Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change | Q81378088 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain | Q1073 |
| dementia | Q83030 | ||
| Alzheimer's disease | Q11081 | ||
| P304 | page(s) | 261-75 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | Nutrition | Q15762858 |
| P1476 | title | Inadequate supply of vitamins and DHA in the elderly: implications for brain aging and Alzheimer-type dementia | |
| P478 | volume | 31 |
| Q36781717 | Alzheimer's Disease Risk and Progression: The Role of Nutritional Supplements and their Effect on Drug Therapy Outcome |
| Q37474472 | Alzheimer's disease patient groups derived from a multivariate analysis of cognitive test outcomes in the Coalition Against Major Diseases dataset |
| Q36605435 | Classification of Single Normal and Alzheimer's Disease Individuals from Cortical Sources of Resting State EEG Rhythms |
| Q55279676 | Comparison of multiple interventions for older adults with Alzheimer disease or mild cognitive impairment: A PRISMA-compliant network meta-analysis. |
| Q48043660 | Delayed Docosahexaenoic Acid Treatment Combined with Dietary Supplementation of Omega-3 Fatty Acids Promotes Long-Term Neurovascular Restoration After Ischemic Stroke |
| Q39014590 | Dietary DHA and health: cognitive function ageing. |
| Q37447138 | Dietary Intake of Nutrients and Lifestyle Affect the Risk of Mild Cognitive Impairment in the Chinese Elderly Population: A Cross-Sectional Study |
| Q50014666 | Dietary Modulation of the Epigenome |
| Q27311387 | Dietary supplementation with omega-3 polyunsaturated fatty acids robustly promotes neurovascular restorative dynamics and improves neurological functions after stroke. |
| Q26768442 | Docosahexaenoic Acid and Cognition throughout the Lifespan |
| Q101162228 | Effects of dietary restriction on metabolic and cognitive health |
| Q51012767 | Effects of exogenous vitamins A, C, and E and NADH supplementation on proliferation, cytokines release, and cell redox status of lymphocytes from healthy aged subjects. |
| Q26864433 | Effects of vitamin E on cognitive performance during ageing and in Alzheimer's disease |
| Q39436409 | Enduring amnesia induced by ICV scopolamine is reversed by sesame oil in male rats |
| Q61818127 | Epigenetic Factors in Late-Onset Alzheimer's Disease: and Gene Polymorphisms, Metabolic Transsulfuration and Methylation Pathways, and B Vitamins |
| Q60934682 | Hyperoside attenuates renal aging and injury induced by D-galactose via inhibiting AMPK-ULK1 signaling-mediated autophagy |
| Q64924479 | N-3 Polyunsatured Fatty Acids in Menopausal Transition: A Systematic Review of Depressive and Cognitive Disorders with Accompanying Vasomotor Symptoms. |
| Q46185330 | Neuroprotective Effect of Ligustilide through Induction of α-Secretase Processing of Both APP and Klotho in a Mouse Model of Alzheimer's Disease |
| Q26745425 | Nutritional Cognitive Neuroscience: Innovations for Healthy Brain Aging |
| Q28068353 | Potential Links between Impaired One-Carbon Metabolism Due to Polymorphisms, Inadequate B-Vitamin Status, and the Development of Alzheimer's Disease |
| Q38820807 | Recent Findings in Alzheimer Disease and Nutrition Focusing on Epigenetics |
| Q48040778 | Role of Omega-3 PUFAs in Neurobiological Health |
| Q57788557 | Something's fishy |
| Q47171672 | Taming Alzheimer's disease: New perspectives, newer horizons |
| Q38705144 | The Association between the Mediterranean Dietary Pattern and Cognitive Health: A Systematic Review. |
| Q28074531 | The Impact of Vitamin E and Other Fat-Soluble Vitamins on Alzheimer´s Disease |
| Q89662262 | Treating impulsivity with probiotics in adults (PROBIA): study protocol of a multicenter, double-blind, randomized, placebo-controlled trial |
| Q47127851 | Vitamin E Supplementation Reduces Cellular Loss in the Brain of a Premature Aging Mouse Model |
Search more.